GSK

Question 1

What is GSK( top down approach)

Answer 1

its a transitional co-operation for profit pharmaceutical industry. Manufacturing in 36 countries and employing 100,000 people globally

Question 2

what major disease breakthroughs have gsk achieved

Answer 2

they developed the first malaria vacinne, medication for type 2 diabetes and the first oncology drug for leukemia

Question 3

why are pharmacies patents important for disease migration

Answer 3

patents last 20 years( a legal right that protects new inventions) they allow companies like GSK to recoup(get money back thats been spent previously) R&D development funding future drug development. GSK holds almost 10,000 patents largely in HIV, cancer and Covid-19

Question 4

How does GSK contribute to global disease

Answer 4

Its one of the only pharmacies that are actively researching new candidate drugs for the WHOS top 3 global priority disease

Question 5

what is the scale of GSK direct contribution to global health

Answer 5

GSK delivers almost a billion vaccines and medicine packs with healthcare products every year

Question 6

what is GSK patent policy in LIDCS

Answer 6

GSK doesnt enforce patents or file new patents in LIDC allowing local companies to manufacture their own versions of GSK medicines

Question 7

what are the main criticisms of GSKs conduct

Answer 7

has historically overcharged governments and indivuals for drugs, has had former employees prosecuted and accused of lobbying governments

Question 8

how does GSK profit

Answer 8

GSK priorities drugs that require long term repeated prescriptions so they are gaurenteed as profitable

Question 9

what are the successes and negatives of this top down approach

Answer 9

Positives
-global impact
-treating vast numbe
-smaller scale programmes cant reach the research and distribution
-huge amount of investment so reduced risk and high chance of eradication

Negatives
-as they are profit organisations it can cause moral and ethical issues